PI3K protein: Potential new therapeutic target in pancreatic neuroendocrine tumors

Posted by on June 17, 2016 2:49 pm
Categories: health

Researchers have demonstrated that selective inactivation of the p110&alpha, PI3K isoform is sufficient to block tumor progression and metastasis in a mice model of PanNETs

Leave a Reply

Your email address will not be published. Required fields are marked *